Furosemide Tablets recalled over manufacturing violations
- Recall date
- March 20, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Leading Pharma, LLC recalls Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004…
- Recall number
- D-0486-2026
- FDA classification
- Class II
- Brand / firm
- Leading Pharma, LLC
- Sold / distributed
- US Nationwide.
Why it was recalled
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Get recall alerts
Free email alert whenever Leading Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Leading Pharma, LLC